We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: Booz Allen Hamilton, ColgatePalmolive and Gentex
Read MoreHide Full Article
For Immediate Release
Chicago, IL – January 30, 2024 – Today, Zacks Investment Ideas feature highlights Booz Allen Hamilton (BAH - Free Report) , ColgatePalmolive (CL - Free Report) and Gentex (GNTX - Free Report) .
3 Standout Stocks to Buy After Earnings
Several stocks from a variety of sectors are standing out after beating earnings expectations last Friday. Following their favorable quarterly results now appears to be a good time to buy as earnings estimate revisions are likely to trend higher in the following weeks.
This could very well lead to a nice amount of upside in these stocks and here are three to consider right now.
Booz Allen Hamilton
We'll start with Booz Allen Hamilton as the management and technology solutions provider was added to the Zacks Rank #1 (Strong Buy) list after posting strong results for its fiscal third quarter last Friday.
Providing cyber expertise, analytics, engineering, and digital solutions to the United States and international governments it's noteworthy that Booz Allen's Zacks Government Services Industry is in the top 1% of over 250 Zacks industries. Correlating with such Q3 earnings of $1.41 per share surpassed the Zacks Consensus of $1.13 a share by 25% and soared 32% from $1.07 a share in the prior-year quarter.
Booz Allen was also able to beat top line estimates by 1.54% with Q3 sales at $2.56 billion. Third quarter sales rose 13% year over year and Booz Allen raised its full-year 2024 outlook. The company now sees revenue growth at 14-15% this year compared to previous forecast of 11-14%. Booz Allen now forecasts adjusted earnings at $5.25-$5.40 per share versus previous guidance of $4.95-$5.10 a share.
In addition to this Booz Allen raised its quarterly dividend by 8% to $0.51 a share and has now boosted its yield seven times in the last five years. Notably, Booz Allen's total return over the last year is a very stellar +56% when including dividends and BAH shares hit 52-week highs of $147.52 last Friday.
ColgatePalmolive
Consumer staples giant Colgate-Palmolive looks attractive following its Q4 results and currently sports a Zacks Rank #2 (Buy). The home care consumer products company and oral hygiene titan posted Q4 earnings of $0.87 a share which beat expectations by 2%. Fourth quarter earnings jumped 13% YoY with sales of $4.95 billion beating estimates by 1% and rising 7% from $4.62 billion in the comparative quarter.
Furthermore, Colgate has now surpassed earnings expectations in each of its last four quarterly reports with its Latin America and Europe region sales propelling the company of late. Latin America and Europe net sales were up 18% and 10% respectively during Q4. Colgate's stock is up a respectable +15% over the last year after hitting 52-week highs of $84 a share today. Plus, Colgate's 2.32% annual dividend yield should keep investors locked in as macroeconomic conditions have improved significantly.
Gentex
Lastly, Gentex sports a Zacks Rank #2 (Buy) with the automotive original equipment manufacturer posting very reassuring Q4 results. As a provider of automatic-dimming rear-view mirrors and electronics, Gentex's Q4 earnings of $0.50 a share topped the Zacks Consensus by 13% with sales of $589.13 million coming in 5% better than expected.
Year over year Q4 EPS climbed 37% from $0.37 a share in the comparative quarter with quarterly sales expanding 19%. Gentex has exceeded earnings expectations in each of its last four quarterly reports posting an impressive average earnings surprise of 12.2%. Quieting fears of a potential negative impact from the UAW strikes, Gentex stock is now up +18% in the last year and is hovering near its 52-week highs of $34.33 a share seen last August. Gentex also offers a modest 1.42% annual dividend yield.
Bottom Line
Booz Allen Hamilton, Colgate-Palmolive, and Gentex have started to reconfirm their growth expectations with many analysts raising their price targets for these stocks after strong quarterly results making now an ideal time to buy.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Zacks Investment Ideas feature highlights: Booz Allen Hamilton, ColgatePalmolive and Gentex
For Immediate Release
Chicago, IL – January 30, 2024 – Today, Zacks Investment Ideas feature highlights Booz Allen Hamilton (BAH - Free Report) , ColgatePalmolive (CL - Free Report) and Gentex (GNTX - Free Report) .
3 Standout Stocks to Buy After Earnings
Several stocks from a variety of sectors are standing out after beating earnings expectations last Friday. Following their favorable quarterly results now appears to be a good time to buy as earnings estimate revisions are likely to trend higher in the following weeks.
This could very well lead to a nice amount of upside in these stocks and here are three to consider right now.
Booz Allen Hamilton
We'll start with Booz Allen Hamilton as the management and technology solutions provider was added to the Zacks Rank #1 (Strong Buy) list after posting strong results for its fiscal third quarter last Friday.
Providing cyber expertise, analytics, engineering, and digital solutions to the United States and international governments it's noteworthy that Booz Allen's Zacks Government Services Industry is in the top 1% of over 250 Zacks industries. Correlating with such Q3 earnings of $1.41 per share surpassed the Zacks Consensus of $1.13 a share by 25% and soared 32% from $1.07 a share in the prior-year quarter.
Booz Allen was also able to beat top line estimates by 1.54% with Q3 sales at $2.56 billion. Third quarter sales rose 13% year over year and Booz Allen raised its full-year 2024 outlook. The company now sees revenue growth at 14-15% this year compared to previous forecast of 11-14%. Booz Allen now forecasts adjusted earnings at $5.25-$5.40 per share versus previous guidance of $4.95-$5.10 a share.
In addition to this Booz Allen raised its quarterly dividend by 8% to $0.51 a share and has now boosted its yield seven times in the last five years. Notably, Booz Allen's total return over the last year is a very stellar +56% when including dividends and BAH shares hit 52-week highs of $147.52 last Friday.
ColgatePalmolive
Consumer staples giant Colgate-Palmolive looks attractive following its Q4 results and currently sports a Zacks Rank #2 (Buy). The home care consumer products company and oral hygiene titan posted Q4 earnings of $0.87 a share which beat expectations by 2%. Fourth quarter earnings jumped 13% YoY with sales of $4.95 billion beating estimates by 1% and rising 7% from $4.62 billion in the comparative quarter.
Furthermore, Colgate has now surpassed earnings expectations in each of its last four quarterly reports with its Latin America and Europe region sales propelling the company of late. Latin America and Europe net sales were up 18% and 10% respectively during Q4. Colgate's stock is up a respectable +15% over the last year after hitting 52-week highs of $84 a share today. Plus, Colgate's 2.32% annual dividend yield should keep investors locked in as macroeconomic conditions have improved significantly.
Gentex
Lastly, Gentex sports a Zacks Rank #2 (Buy) with the automotive original equipment manufacturer posting very reassuring Q4 results. As a provider of automatic-dimming rear-view mirrors and electronics, Gentex's Q4 earnings of $0.50 a share topped the Zacks Consensus by 13% with sales of $589.13 million coming in 5% better than expected.
Year over year Q4 EPS climbed 37% from $0.37 a share in the comparative quarter with quarterly sales expanding 19%. Gentex has exceeded earnings expectations in each of its last four quarterly reports posting an impressive average earnings surprise of 12.2%. Quieting fears of a potential negative impact from the UAW strikes, Gentex stock is now up +18% in the last year and is hovering near its 52-week highs of $34.33 a share seen last August. Gentex also offers a modest 1.42% annual dividend yield.
Bottom Line
Booz Allen Hamilton, Colgate-Palmolive, and Gentex have started to reconfirm their growth expectations with many analysts raising their price targets for these stocks after strong quarterly results making now an ideal time to buy.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.